No images? Click here Monday 12 April MEDIA ADVISORY Subject: Antibacterial agents in clinical and preclinical development report On April 15th, 2021 the WHO will launch its new 2020 Antibacterial agents in clinical and preclinical development report. On the same day, the WHO will hold a one-hour press conference on the report at 14:00 CEST. The report examines the current global development pipeline for new antibacterial treatments, including for tuberculosis, in the context of the silent pandemic of antibacterial resistance. At the press conference, the WHO will briefly present the report highlighting some of the main results, this will be followed by a Q&A session. Speakers: Dr. Peter Beyer, Unit Head, Antimicrobial Resistance (AMR) Global coordination and Partnership (GCP) Press release, the new report 2020 Antibacterial agents in clinical and preclinical development: an overview and analysis and infographics (UNDER EMBARGO until Thursday 15 April, 8:00 CEST) can be downloaded from here. Join the press conference: Link: https://who-e.zoom.us/j/95460962571 Password: p1p3l1ne By phone: Webinar ID: 954 6096 2571 Numeric passcode for phone: 49447917 International numbers available: https://who-e.zoom.us/u/acxzlAIA8B Media contacts: You are receiving this NO-REPLY email because you are included on a WHO mail list. |
Monday, April 12, 2021
MEDIA ADVISORY: Press Conference on Antibacterial agents in clinical and preclinical development report - 15 April
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment